Lagente, V.
75  Ergebnisse:
Personensuche X
?
1

The NLRP3 inflammasome is activated by nanoparticles throug..:

Baron, L ; Gombault, A ; Fanny, M...
Cell Death & Disease.  6 (2015)  2 - p. e1629-e1629 , 2015
 
?
2

The selective MMP‐12 inhibitor, AS111793 reduces airway inf..:

Le Quément, C ; Guénon, I ; Gillon, J‐Y...
British Journal of Pharmacology.  154 (2008)  6 - p. 1206-1215 , 2008
 
?
 
?
5

Timp-1 is a Key Factor of Fibrogenic Response to Bleomycin ..:

Manoury, B. ; Caulet-Maugendre, S. ; Guénon, I...
International Journal of Immunopathology and Pharmacology.  19 (2006)  3 - p. 471-487 , 2006
 
?
6

The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits ..:

Ouagued, M. ; Martin-Chouly, C.A.E. ; Brinchault, G....
Pulmonary Pharmacology & Therapeutics.  18 (2005)  1 - p. 49-54 , 2005
 
?
 
?
8

Interactions of tachykinin receptor antagonists with lipopo..:

Veron, M ; Guenon, I ; Nenan, S...
Clinical and Experimental Pharmacology and Physiology.  31 (2004)  9 - p. 634-640 , 2004
 
?
9

Deficiency in reactive oxygen species in p47phox-/-mice att..:

Manoury, B. ; Leclerc, O. ; Nénan, S....
Inflammation Research.  52 (2003)  S2 - p. S190-S193 , 2003
 
?
10

Enhancement of gelatinase activity during development of su..:

Corbel, M. ; Caulet‐Maugendre, S. ; Germain, N...
Clinical & Experimental Allergy.  33 (2003)  5 - p. 696-704 , 2003
 
?
11

Increased release of matrix metalloproteinase‐9 in the plas..:

Belleguic, C. ; Corbel, M. ; Germain, N....
Clinical & Experimental Allergy.  32 (2002)  2 - p. 217-223 , 2002
 
?
12

DMSO-treated HL60 cells: a model of neutrophil-like cells m..:

Jacob, C ; Leport, M ; Szilagyi, C...
International Immunopharmacology.  2 (2002)  12 - p. 1647-1656 , 2002
 
?
14

Les inhibiteurs des phosphodiestérases de type 4:

Lagente, V. ; Belleguic, C. ; Martins, M.A...
Revue Française d'Allergologie et d'Immunologie Clinique.  40 (2000)  3 - p. 336-342 , 2000
 
?
15

Endotoxin-induced Acute Lung Injury in Rats. Role of Insuli:

Boichot, E. ; Sannomiya, P. ; Escofier, N....
Pulmonary Pharmacology & Therapeutics.  12 (1999)  5 - p. 285-290 , 1999
 
1-15